微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 58% | -0.99% | 4.9% | 58/160 | 22.89% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 55.3% | -1.3% | -3.27% | 68/160 | 33.26% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 57.17% | -2.91% | 2.46% | 57/160 | 51.37% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 55.79% | -11.45% | -4.76% | 68/160 | 51.37% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 58.58% | -6.27% | 4.56% | 61/160 | 32.75% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 56.03% | -9.57% | -4.85% | 66/160 | 38.61% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 58.88% | -7.39% | -6.56% | 57/160 | 52.91% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 63.01% | 12.07% | 0.81% | 54/160 | 53.57% | 迈威生物 | 99.75% | 行业排名> |
| 2022-09-30 | 62.5% | 8.03% | 0.89% | 53/160 | 6.69% | 迈威生物 | 99.67% | 行业排名> |
| 2022-06-30 | 61.95% | 9.7% | -2.56% | 56/160 | 21.79% | 迈威生物 | 99.44% | 行业排名> |
| 2022-03-31 | 63.58% | 17.23% | 13.07% | 49/160 | 54.47% | 迈威生物 | 98.57% | 行业排名> |
| 2021-12-31 | 56.23% | 2.37% | -2.81% | 72/160 | 55.07% | 首药控股 | 99.93% | 行业排名> |
| 2021-09-30 | 57.85% | -0.54% | 2.45% | 59/160 | 47.01% | 艾力斯 | 99.41% | 行业排名> |
| 2021-06-30 | 56.47% | -4.54% | 4.14% | 68/160 | 47.45% | 艾力斯 | 98.7% | 行业排名> |
| 2021-03-31 | 54.23% | -13.12% | -1.27% | 68/160 | 54.21% | 艾力斯 | 99.4% | 行业排名> |
| 2020-12-31 | 54.93% | -14.24% | -5.58% | 71/160 | -143.08% | 首药控股 | 99.94% | 行业排名> |
| 2020-09-30 | 58.17% | -6.23% | -1.67% | 56/160 | 56.57% | 泽璟制药 | 99.96% | 行业排名> |
| 2020-06-30 | 59.16% | 2% | -5.23% | 55/160 | 54.32% | 微芯生物 | 95.14% | 行业排名> |
| 2020-03-31 | 62.42% | -0.87% | -2.53% | 44/160 | 55.5% | 多瑞医药 | 95.59% | 行业排名> |
| 2019-12-31 | 64.04% | 9.56% | 3.24% | 48/160 | -1204.25% | 微芯生物 | 95.81% | 行业排名> |
| 2019-09-30 | 62.03% | 2% | -1.48% | 43/160 | 55.47% | 微芯生物 | 96.09% | 行业排名> |
| 2019-03-31 | 62.97% | 2% | 7.72% | 38/160 | 51.37% | 微芯生物 | 96.11% | 行业排名> |
| 2018-12-31 | 58.45% | -0.8% | -0.8% | 58/160 | -205.91% | 微芯生物 | 95.5% | 行业排名> |
| 2017-12-31 | 58.93% | 2.17% | 2.17% | 45/160 | 52.58% | 微芯生物 | 96.27% | 行业排名> |
| 2016-12-31 | 57.67% | 2% | 2% | 36/160 | 48.44% | 贝达药业 | 95.47% | 行业排名> |